Clinical Research Directory
Browse clinical research sites, groups, and studies.
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
Sponsor: Theresa Jacob, PhD, MPH
Summary
The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence of opioid withdrawal symptoms and improved quality of life.
Official title: Buprenorphine Tx:A Safe Alternative for Opioid Dependent Pain Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
4
Start Date
2013-02
Completion Date
2013-08
Last Updated
2026-05-08
Healthy Volunteers
No
Interventions
Buprenorphine/Naloxone
Sublingual buprenorphine/naloxone taken in a 3 day induction, with a final daily dose (up to 32 mg depending on the subject) taken daily, as prescribed by the study psychiatrist. Subjects will continue buprenorphine for study duration (6 months).
Locations (1)
Maimonides Medical Center
Brooklyn, New York, United States